Compound 497
Identifiers
- Canonical SMILES:
Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1ccc(cc1)C(=O)N[C@H]1C[C@@H]1c1ccccc1
- IUPAC name:
4-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]-N-[(1S,2R)-2-phenylcyclopropyl]benzamide
- InChi:
InChI=1S/C30H25Cl2FN2O4S/c31-23-14-26(32)29(36)28(15-23)40(38,39)35(18-20-8-12-24(33)13-9-20)17-19-6-10-22(11-7-19)30(37)34-27-16-25(27)21-4-2-1-3-5-21/h1-15,25,27,36H,16-18H2,(H,34,37)/t25-,27+/m1/s1
- InChiKey:
ZIZYQNAEKNJPSR-VPUSJEBWSA-N
External links
58531586 |
External search
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 143 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.43 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 598.09 g/mol | |||
HBA | 6 | |||
HBD | 2 | |||
HBA + HBD | 8 | |||
AlogP | 6.56 | |||
TPSA | 86.71 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 143 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.43 | |
WO2009152082 | 143 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.35 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5497 | Glyburide | DB01016 | |
0.5146 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.5098 | N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide | DB03596 | |
0.4964 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4948 | Repinotan | DB06506 | |
0.4933 | Saredutant | DB06660 | |
0.4774 | Osanetant | DB04872 | |
0.4754 | 2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid | DB03207 | |
0.4695 | PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE | DB07710 | |
0.4651 | Evatanepag | DB12022 | |
0.4650 | Avagacestat | DB11893 | |
0.4630 | Vidupiprant | DB12272 | |
0.4604 | 4-Sulfonamide-[1-(4-Aminobutane)]Benzamide | DB03697 | |
0.4599 | ABT-639 | DB15055 | |
0.4598 | 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide | DB02429 |